The World Market for Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding Yeasts: A 2009 Global Trade Perspective

This report was created for strategic planners, international executives and import/export managers who are concerned with the market for human blood, prepared animal blood, toxins, cultures of micro-organisms, and similar products excluding yeasts. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for human blood, prepared animal blood, toxins, cultures of micro-organisms, and similar products excluding yeasts for those countries serving the world market via exports or supplying from various countries via imports. I do so for the current year based on a variety of key historical indicators and econometric models.

On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying human blood, prepared animal blood, toxins, cultures of micro-organisms, and similar products excluding yeasts? What is the dollar value of these imports? How much do the imports of human blood, prepared animal blood, toxins, cultures of micro-organisms, and similar products excluding yeasts vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of human blood, prepared animal blood, toxins, cultures of micro-organisms, and similar products excluding yeasts? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?

In what follows, Chapter 2 begins by summarizing the regional markets for imported and exported human blood, prepared animal blood, toxins, cultures of micro-organisms, and similar products excluding yeasts. The total level of imports and exports on a worldwide basis, and those for each region, is based on a model which aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on both demand- and supply-side dynamics, market shares by country of origin are then calculated across each country market destination. These shares lead to a volume of import and export values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each market and the shares that countries are likely to receive this year. From these figures, rankings are calculated to allow managers to prioritize markets. In this way, all the figures provided in this report are forecasts that can be combined with internal information for strategic planning purposes.

After the worldwide summary in Chapter 2 of both imports and exports, Chapter 3 details the exports of human blood, prepared animal blood, toxins, cultures of micro-organisms, and similar products excluding yeasts, for each individual country. Chapter 4 does the same, but for imports of human blood, prepared animal blood, toxins, cultures of micro-organisms, and similar products excluding yeasts for all countries in the world. In all cases, the total dollar volume and percentage share values by major trading partner are provided. Combined, Chapters 3 and 4 present the complete picture for imports and exports of human blood, prepared animal blood, toxins, cultures of micro-organisms, and similar products excluding yeasts to and from all major countries in the world. Of the 150 countries considered, if a country is not reported here it is therefore estimated to have only a negligible level of trade in human blood, prepared animal blood, toxins, cultures of micro-organisms, and similar products excluding yeasts (i.e. their market shares are close or equal to zero percent). "Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding Yeasts" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defined "human blood, prepared animal blood, toxins, cultures of micro-organisms, and similar products excluding yeasts" is 54164 . SHOW LESS READ MORE >

1 METHODOLOGY 11
1.1 Our Approach 11
2 THE WORLD MARKET 15
2.1 Exports 15
2.1.1 The World Market: Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding Yeasts Export Supplies in 2009 15
2.2 Imports 18
2.2.1 The World Market: Imported Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding Yeasts in 2009 18
3 EXPORTS 22
3.1 Africa: Export Supplies of Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding 22
3.1.1 Executive Summary 22
3.1.2 Kenya 24
3.1.3 Malawi 24
3.1.4 South Africa 25
3.1.5 Zambia 25
3.2 Asia: Export Supplies of Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding 25
3.2.1 Executive Summary 26
3.2.2 China 29
3.2.3 Hong Kong 30
3.2.4 India 30
3.2.5 Indonesia 31
3.2.6 Japan 32
3.2.7 Malaysia 33
3.2.8 North Korea 33
3.2.9 Singapore 33
3.2.10 South Korea 34
3.2.11 Taiwan 34
3.2.12 Thailand 35
3.3 Europe: Export Supplies of Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding 35
3.3.1 Executive Summary 35
3.3.2 Austria 40
3.3.3 Belgium 41
3.3.4 Bulgaria 42
3.3.5 Croatia 42
3.3.6 Cyprus 42
3.3.7 Czech Republic 43
3.3.8 Denmark 44
3.3.9 Estonia 45
3.3.10 Finland 46
3.3.11 France 47
3.3.12 Germany 48
3.3.13 Greece 49
3.3.14 Hungary 49
3.3.15 Ireland 50
3.3.16 Italy 51
3.3.17 Latvia 52
3.3.18 Lithuania 52
3.3.19 Luxembourg 52
3.3.20 Norway 53
3.3.21 Poland 53
3.3.22 Romania 54
3.3.23 Russia 54
3.3.24 Slovakia 54
3.3.25 Slovenia 55
3.3.26 Spain 56
3.3.27 Sweden 57
3.3.28 Switzerland 58
3.3.29 the Netherlands 59
3.3.30 the United Kingdom 60
3.3.31 Ukraine 61
3.4 Latin America: Export Supplies of Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products 61
3.4.1 Executive Summary 61
3.4.2 Argentina 63
3.4.3 Brazil 64
3.4.4 Chile 64
3.4.5 Colombia 64
3.4.6 Mexico 65
3.4.7 Panama 65
3.4.8 Uruguay 65
3.5 North America & the Caribbean: Export Supplies of Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and 66
3.5.1 Executive Summary 66
3.5.2 Canada 69
3.5.3 Cuba 70
3.5.4 the United States 71
3.6 Oceana: Export Supplies of Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding 72
3.6.1 Executive Summary 72
3.6.2 Australia 75
3.6.3 New Zealand 76
3.7 the Middle East: Export Supplies of Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products 76
3.7.1 Executive Summary 76
3.7.2 Armenia 79
3.7.3 Iran 79
3.7.4 Israel 80
3.7.5 Jordan 80
3.7.6 Saudi Arabia 81
3.7.7 the United Arab Emirates 81
3.7.8 Turkey 81
4 IMPORTS 82
4.1 Africa: Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding Yeasts Imports in 82
4.1.1 Executive Summary 82
4.1.2 Algeria 85
4.1.3 Botswana 86
4.1.4 Cameroon 86
4.1.5 Cote dIvoire 86
4.1.6 Egypt 87
4.1.7 Ethiopia 87
4.1.8 Gabon 88
4.1.9 Ghana 88
4.1.10 Madagascar 88
4.1.11 Malawi 89
4.1.12 Mauritania 89
4.1.13 Morocco 90
4.1.14 Namibia 90
4.1.15 Senegal 90
4.1.16 South Africa 91
4.1.17 Sudan 91
4.1.18 Tanzania 92
4.1.19 Uganda 92
4.2 Asia: Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding Yeasts Imports in 2009 92
4.2.1 Executive Summary 93
4.2.2 Brunei 96
4.2.3 China 97
4.2.4 Hong Kong 98
4.2.5 India 99
4.2.6 Indonesia 100
4.2.7 Japan 101
4.2.8 Malaysia 102
4.2.9 Mongolia 102
4.2.10 Philippines 103
4.2.11 Singapore 103
4.2.12 South Korea 104
4.2.13 Taiwan 105
4.2.14 Thailand 105
4.3 Europe: Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding Yeasts Imports in 106
4.3.1 Executive Summary 106
4.3.2 Albania 110
4.3.3 Austria 111
4.3.4 Belarus 112
4.3.5 Belgium 113
4.3.6 Bosnia and Herzegovina 114
4.3.7 Bulgaria 114
4.3.8 Croatia 115
4.3.9 Cyprus 115
4.3.10 Czech Republic 116
4.3.11 Denmark 117
4.3.12 Estonia 118
4.3.13 Finland 119
4.3.14 France 120
4.3.15 Georgia 121
4.3.16 Germany 122
4.3.17 Greece 123
4.3.18 Hungary 124
4.3.19 Iceland 124
4.3.20 Ireland 125
4.3.21 Italy 126
4.3.22 Kazakhstan 127
4.3.23 Latvia 128
4.3.24 Lithuania 129
4.3.25 Luxembourg 129
4.3.26 Macedonia 130
4.3.27 Malta 130
4.3.28 Moldova 130
4.3.29 Norway 131
4.3.30 Poland 132
4.3.31 Portugal 133
4.3.32 Romania 134
4.3.33 Russia 135
4.3.34 Slovakia 136
4.3.35 Slovenia 137
4.3.36 Spain 138
4.3.37 Sweden 139
4.3.38 Switzerland 140
4.3.39 the Netherlands 141
4.3.40 the United Kingdom 142
4.3.41 Ukraine 143
4.4 Latin America: Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding Yeasts 143
4.4.1 Executive Summary 143
4.4.2 Argentina 146
4.4.3 Bolivia 147
4.4.4 Brazil 148
4.4.5 Chile 149
4.4.6 Colombia 150
4.4.7 Costa Rica 151
4.4.8 Ecuador 151
4.4.9 El Salvador 152
4.4.10 Guatemala 152
4.4.11 Guyana 153
4.4.12 Honduras 153
4.4.13 Mexico 154
4.4.14 Nicaragua 154
4.4.15 Panama 155
4.4.16 Paraguay 155
4.4.17 Peru 156
4.4.18 Uruguay 157
4.4.19 Venezuela 158
4.5 North America & the Caribbean: Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products 158
4.5.1 Executive Summary 158
4.5.2 Barbados 161
4.5.3 Canada 162
4.5.4 Jamaica 163
4.5.5 the United States 164
4.5.6 Trinidad and Tobago 165
4.6 Oceana: Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding Yeasts Imports in 165
4.6.1 Executive Summary 165
4.6.2 Australia 167
4.6.3 Fiji 168
4.6.4 New Caledonia 168
4.6.5 New Zealand 169
4.7 the Middle East: Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding Yeasts 169
4.7.1 Executive Summary 169
4.7.2 Armenia 172
4.7.3 Azerbaijan 173
4.7.4 Bahrain 173
4.7.5 Iran 173
4.7.6 Israel 174
4.7.7 Jordan 174
4.7.8 Kyrgyzstan 175
4.7.9 Oman 175
4.7.10 Pakistan 176
4.7.11 Qatar 176
4.7.12 Saudi Arabia 177
4.7.13 Turkey 177
4.7.14 Yemen 178
5 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 179
5.1 Disclaimers & Safe Harbor 179
5.2 ICON Group Ltd. User Agreement Provisions 180